123 related articles for article (PubMed ID: 22499523)
1. [Advances on Golgi glycoprotein 73 and its association with diseases].
Jiang JC; Zhou LF
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2012 Mar; 41(2):215-21. PubMed ID: 22499523
[TBL] [Abstract][Full Text] [Related]
2. [Detection and evaluation of serum GP73, a resident Golgi glycoprotein, as a marker in diagnosis of hepatocellular carcinoma].
Zhao XY; Li N; Ding HG; Jiang FF
Zhonghua Zhong Liu Za Zhi; 2010 Dec; 32(12):943-5. PubMed ID: 21223806
[TBL] [Abstract][Full Text] [Related]
3. Development and potential application of a simultaneous multiplex assay of Golgi protein 73 and alpha-fetoprotein for hepatocellular carcinoma diagnosis.
Xiao J; Long F; Peng T; Hu LB; Cai H; Chen R; Chen WL
Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3302-3310. PubMed ID: 31081083
[TBL] [Abstract][Full Text] [Related]
4. [Significance of Golgi glycoprotein 73, a new tumor marker in diagnosis of hepatocellular carcinoma: a primary study].
Mao YL; Yang HY; Xu HF; Sang XT; Lu X; Yang ZY; Zhang JC; Zhong SX; Huang JF; Zhang HB
Zhonghua Yi Xue Za Zhi; 2008 Apr; 88(14):948-51. PubMed ID: 18756964
[TBL] [Abstract][Full Text] [Related]
5. GP73, a resident Golgi glycoprotein, is a novel serum marker for hepatocellular carcinoma.
Marrero JA; Romano PR; Nikolaeva O; Steel L; Mehta A; Fimmel CJ; Comunale MA; D'Amelio A; Lok AS; Block TM
J Hepatol; 2005 Dec; 43(6):1007-12. PubMed ID: 16137783
[TBL] [Abstract][Full Text] [Related]
6. Possible roles of Golgi protein-73 in liver diseases.
Liu MY; Huang L; Wu JF; Zhang HB; Ai WB; Zhang RT
Ann Hepatol; 2022; 27(5):100720. PubMed ID: 35577277
[TBL] [Abstract][Full Text] [Related]
7. Golgi protein 73, not Glypican-3, may be a tumor marker complementary to α-Fetoprotein for hepatocellular carcinoma diagnosis.
Wang Y; Yang H; Xu H; Lu X; Sang X; Zhong S; Huang J; Mao Y
J Gastroenterol Hepatol; 2014 Mar; 29(3):597-602. PubMed ID: 24236824
[TBL] [Abstract][Full Text] [Related]
8. Golgi protein-73: A biomarker for assessing cirrhosis and prognosis of liver disease patients.
Gatselis NK; Tornai T; Shums Z; Zachou K; Saitis A; Gabeta S; Albesa R; Norman GL; Papp M; Dalekos GN
World J Gastroenterol; 2020 Sep; 26(34):5130-5145. PubMed ID: 32982114
[TBL] [Abstract][Full Text] [Related]
9. GP73 expression and its significance in the diagnosis of hepatocellular carcinoma: a review.
Ba MC; Long H; Tang YQ; Cui SZ
Int J Clin Exp Pathol; 2012; 5(9):874-81. PubMed ID: 23119104
[TBL] [Abstract][Full Text] [Related]
10. Identification and characterization of monoclonal antibodies against GP73 for use as a potential biomarker in liver cancer screening and diagnosis.
Zhang Y; Xi Y; Fang J; Luo S; Wilson JJ; Huang RP
J Immunoassay Immunochem; 2016; 37(4):390-406. PubMed ID: 27088654
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of individual and combined applications of serum biomarkers for diagnosis of hepatocellular carcinoma: a meta-analysis.
Hu B; Tian X; Sun J; Meng X
Int J Mol Sci; 2013 Dec; 14(12):23559-80. PubMed ID: 24317431
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of circulating Transforming growth factor-beta1, Glypican-3 and Golgi protein-73 mRNAs expression as predictive markers for hepatocellular carcinoma in Egyptian patients.
Ibrahim GH; Mahmoud MA; Aly NM
Mol Biol Rep; 2013 Dec; 40(12):7069-75. PubMed ID: 24186850
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic Value of the Combination of Golgi Protein 73 and Alpha-Fetoprotein in Hepatocellular Carcinoma: A Meta-Analysis.
Dai M; Chen X; Liu X; Peng Z; Meng J; Dai S
PLoS One; 2015; 10(10):e0140067. PubMed ID: 26441340
[TBL] [Abstract][Full Text] [Related]
14. Endosomal trafficking and proprotein convertase cleavage of cis Golgi protein GP73 produces marker for hepatocellular carcinoma.
Bachert C; Fimmel C; Linstedt AD
Traffic; 2007 Oct; 8(10):1415-23. PubMed ID: 17662025
[TBL] [Abstract][Full Text] [Related]
15. The predictive value of Golgi protein 73 in differentiating benign from malignant liver tumors.
Bröker ME; Ijzermans JN; Witjes CD; van Vuuren HJ; de Man RA
PLoS One; 2014; 9(7):e100187. PubMed ID: 25033446
[TBL] [Abstract][Full Text] [Related]
16. Serum GP73 is complementary to AFP and GGT-II for the diagnosis of hepatocellular carcinoma.
Hou SC; Xiao MB; Ni RZ; Ni WK; Jiang F; Li XY; Lu CH; Chen BY
Oncol Lett; 2013 Oct; 6(4):1152-1158. PubMed ID: 24137480
[TBL] [Abstract][Full Text] [Related]
17. The diagnostic value of golgi protien-73 and DICKKOPF-1 in hepatocellular carcinoma.
ElZefzafy WM; Hussien M; Mohmmed ZAZ; Abd Elbaky NM
J Immunoassay Immunochem; 2021 Mar; 42(2):174-187. PubMed ID: 33284721
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic value of alpha-fetoprotein-L3 and Golgi protein 73 in hepatocellular carcinomas with low AFP levels.
Xu WJ; Guo BL; Han YG; Shi L; Ma WS
Tumour Biol; 2014 Dec; 35(12):12069-74. PubMed ID: 25209179
[TBL] [Abstract][Full Text] [Related]
19. Multiple lectin assays for detecting glyco-alteration of serum GP73 in liver diseases.
Jiang K; Shang S; Li W; Guo K; Qin X; Zhang S; Liu Y
Glycoconj J; 2015 Dec; 32(9):657-64. PubMed ID: 26342810
[TBL] [Abstract][Full Text] [Related]
20. Golgi protein 73 versus alpha-fetoprotein as a biomarker for hepatocellular carcinoma: a diagnostic meta-analysis.
Zhou Y; Yin X; Ying J; Zhang B
BMC Cancer; 2012 Jan; 12():17. PubMed ID: 22244200
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]